GlassScriptPhysician profile
William J Mcshane
NPI 1033189667
$721.20
in general payments reported to CMS, 2019-2025
13 companies · $119 in 2025
The $119 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $408 · 2021: $37.79 · 2022: $139 · 2023: $16.76 · 2025: $119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $136.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $135.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $153.08 | 2019 | |
| Integra Lifesciences Corporation | $131.07 | 2019 | |
| Biocomposites INC | $100.00 | 2025 | Stimulan |
| Kerecis Limited | $88.86 | 2019 | |
| Djo, LLC | $70.02 | 2022 | |
| Alfasigma USA, INC. | $37.79 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $30.56 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $20.86 | 2022 | |
| Dynasplint Systems INC. | $19.75 | 2019 | |
| Advanced Oxygen Therapy INC. | $18.89 | 2025 | Topical Oxygen Chamber For Extremities |
| Horizon Therapeutics Plc | $17.88 | 2022 | |
| Sebela Pharmaceuticals INC. | $16.76 | 2023 | Naftin, Pramosone |
| Melinta Therapeutics, LLC | $15.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Mcshane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.